Electrophysiological characterization of dopamine neuronal activity in the ventral tegmental area across the light-dark cycle

Synapse

Volumn 68, Issue 10, 2014, Pages 454-467

  Domínguez López, Sergio ^a   Howell, Rebecca Dean ^a   López Canúl, Martha Graciela ^a,b   Leyton, Marco ^a,c   Gobbi, Gabriella ^a  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSIDAD VERACRUZANA   (Mexico)

^c Center for Studies in Behavioral Neurobiology Concordia University ^*  (Canada)

Author keywords

Amphetamine; Apomorphine; Cosinor; Diurnal rhythm; Firing activity

Indexed keywords

AMPHETAMINE; APOMORPHINE; DOPAMINE; MELATONIN; CENTRAL DEPRESSANT AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; DOPAMINE UPTAKE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN ELECTROPHYSIOLOGY; CIRCADIAN RHYTHM; CONTROLLED STUDY; ELECTROENCEPHALOGRAM; LIGHT DARK CYCLE; MALE; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT; VENTRAL TEGMENTUM; ACTION POTENTIAL; ANIMAL; DOPAMINERGIC NERVE CELL; DOSE RESPONSE; DRUG EFFECTS; MICROELECTRODE; PHOTOPERIODICITY; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ACTION POTENTIALS; AMPHETAMINE; ANIMALS; APOMORPHINE; CENTRAL NERVOUS SYSTEM DEPRESSANTS; CIRCADIAN RHYTHM; DOPAMINE AGONISTS; DOPAMINE UPTAKE INHIBITORS; DOPAMINERGIC NEURONS; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MELATONIN; MICROELECTRODES; PHOTOPERIOD; RATS, SPRAGUE-DAWLEY; VENTRAL TEGMENTAL AREA;

EID: 84906101739     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.21757     Document Type: Article

References (92)

1. Adi N, Mash DC, Ali Y, Singer C, Shehadeh L, Papapetropoulos S. 2010. Melatonin MT1 and MT2 receptor expression in Parkinson's disease. Med Sci Monit 16:BR61-BR67.
2. Adell A, Artigas F. 2004. The somatodendritic release of dopamine in the ventral tegmental area and its regulation by afferent transmitter systems. Neurosci Biobehav Rev 28:415-431.
3. Andersson JL, Marcus M, Nomikos GG, Svensson TH. 1994. Prazosin modulates the changes in firing pattern and transmitter release induced by raclopride in the mesolimbic, but not in the nigrostriatal dopaminergic system. Naunyn Schmiedebergs Arch Pharmacol 349:236-243.
4. Anzalone A, Lizardi-Ortiz JE, Ramos M, De Mei C, Hopf FW, Iaccarino C, Halbout B, Jacobsen J, Kinoshita C, Welter M, Caron MG, Bonci A, Sulzer D, Borrelli E. 2012. Dual control of dopamine synthesis and release by presynaptic and postsynaptic dopamine D2 receptors. J Neurosci 32:9023-9034.
5. Aston-Jones G, Chen S, Zhu Y, Oshinsky M. 2001. A neural circuit for circadian regulation of arousal. Nat Neurosci 4:732-738.
6. Balfour ME, Yu L, Coolen LM. 2004. Sexual behavior and sex-associated environmental cues activate the mesolimbic system in male rats. Neuropsychopharmacology 29:718-730.
7. Baltazar RM, Coolen LM, Webb IC. 2013. Diurnal rhythms in neural activation in the mesolimbic reward system: critical role of the medial prefrontal cortex. Eur J Neurosci 38:2319-2327.
8. Barnett AG, Dobson AJ. 2010. Analysing seasonal health data. Berlin Heidelberg: Springer-Verlag. p 75-87.
9. Boyd KN, Mailman RB. 2012. Dopamine receptor signaling and current and future antipsychotic drugs. Handb Exp Pharmacol 212:53-86.
10. Bunney BS, Aghajanian GK. 1978. D-amphetamine-induced depression of central dopamine neurons: evidence for mediation by both autoreceptors and a striato-nigral feedback pathway. Naunyn Schmiedebergs Arch Pharmacol 304:255-261.
11. Bunney BS, Grace AA. 1978. Acute and haloperidol treatment: Comparison of effects on nigral dopaminergic cell activity. Life Sci 23:1715-1727.
12. Bunney BS, Walters JR, Roth RH, Aghajanian GK. 1973. Dopaminergic neurons: Effect of antipsychotic drugs and amphetamine on single cell activity. J Pharmacol Exp Ther 185:560-571.
13. Cardinali DP, Nagle CA, Freire F, Rosner JM. 1975. Effects of melatonin on neurotransmitter uptake and release by synaptosome-rich homogenates of the rat hypothalamus. Neuroendocrinology 18:72-85.
14. Carlson JH, Bergstrom DA, Walters JR. 1987. Stimulation of both D1 and D2 dopamine receptors appears necessary for full expression of postsynaptic effects of dopamine agonists: A neurophysiological study. Brain Res 400:205-218.
15. Castaneda TR, de Prado BM, Prieto D, Mora F. 2004. Circadian rhythms of dopamine, glutamate and GABA in the striatum and nucleus accumbens of the awake rat: Modulation by light. J Pineal Res 36:177-185.
16. Castillo Romero JL, Vives Montero F, Acuna Castroviejo D. 1992. Paradoxical effects of melatonin on spontaneous neuronal activity in the striatum of sham-operated and pinealectomized rats. J Pineal Res 12:149-154.
17. Chai B, Meltzer HY. 1992. The effect of chronic clozapine on basal dopamine release and apomorphine-induced DA release in the striatum and nucleus accumbens as measured by in vivo brain microdialysis. Neurosci Lett 140:47-50.
18. Chenu F, El Mansari M, Blier P. 2013. Electrophysiological effects of repeated administration of agomelatine on the dopamine, norepinephrine, and serotonin systems in the rat brain. Neuropsychopharmacol 38:275-284.
19. Chenu F, Shim S, El Mansari M, Blier P. 2014. Role of melatonin, serotonin 2B, and serotonin 2C receptors in modulating the firing activity of rat dopamine neurons. J Psychopharmacol 28:162-167.
20. Chiodo LA, Bannon MJ, Grace AA, Roth RH, Bunney BS. 1984. Evidence for the absence of impulse-regulating somatodendritic and synthesis-modulating nerve terminal autoreceptors on subpopulations of mesocortical dopamine neurons. Neuroscience 12:1-16.
21. Chiodo LA, Bunney BS. 1983. Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons. J Neurosci 3:1607-1619.
22. Daberkow DP, Brown HD, Bunner KD, Kraniotis SA, Doellman MA, Ragozzino ME, Garris PA, Roitman MF. 2013. Amphetamine paradoxically augments exocytotic dopamine release and phasic dopamine signals. J Neurosci 33:452-463.
23. Descarries L, Mechawar N. 2000. Ultrastructural evidence for diffuse transmission by monoamine and acetylcholine neurons of the central nervous system. Prog Brain Res 125:27-47.
24. Di Chiara G, Imperato A. 1988. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA 85:5274-5278.
25. Diana M, Tepper JM. 2002. Electrophysiological pharmacology of mesencephalic dopaminergic neurons. In: Di Chiara G, editor. Handbook of experimental pharmacology, Vol. 154/II. Dopamine in the CNS II. Berlin Heidelberg: Springer-Verlag. p 1-61.
26. Dobi A, Margolis EB, Wang HL, Harvey BK, Morales M. 2010. Glutamatergic and nonglutamatergic neurons of the ventral tegmental area establish local synaptic contacts with dopaminergic and nondopaminergic neurons. J Neurosci 30:218-229.
27. Dominguez-Lopez S, Mahar I, Bambico FR, Labonte B, Ochoa-Sanchez R, Leyton M, Gobbi G. 2012. Short-term effects of melatonin and pinealectomy on serotonergic neuronal activity across the light-dark cycle. J Psychopharmacol 26:830-844.
28. Dubocovich ML, Delagrange P, Krauze DN, Sugden D, Cardinali DP, Olcese J. 2010. International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, classification, and pharmacology of G protein-coupled melatonin receptors. Pharmacol Rev 62:343-380.
29. Eriksen Jmmm, Jorgensen T, Gether U. 2010. Regulation of dopamine transporter function by protein-protein interactions: New discoveries and methodological challenges. J Neurochem 113:27-41.
30. Eulitz D, Prüss H, Derst C, Veh RW. 2007. Heterogeneous distribution of kirk3 potassium channel proteins within dopaminergic neruons in the mesencephalon of the rat brain. Cell Mol Neurobiol 27:285-302.
31. Ford CP. 2014. The role of D2-autoreceptors in regulating dopamine neuron activity and transmission. Neuroscience S0306-4522:00037-2.
32. Floresco SB, West Ar Ash B, Moore H, Grace AA. 2003. Afferent modulation of dopaminergic neurons firing differentially regulates tonic and phasic dopamine transmission. Nat Neurosci 6:968-973.
33. Freeman AS, Bunney BS. 1987. Activity of A9 and A10 dopaminergic neurons in unrestrained rats: further characterization and effects of apomorphine and cholecystokinin. Brain Res 405:46-55.
34. Fuxe K, Dahlström A, Höistad M, Marcellino D, Jansson A, Rivera A, Diaz-Cabiale Z, Jacobsen K, Tinner-Staines B, Hagman B, Leo G, Staines W, Guidolin D, Kehr J, Genedani S, Belluardo N, Agnati LF. 2007. From the Golgi-Cajal mapping to the transmitter-based characterization of the neuronal networks leading to two modes of brain communication: wiring and volume transmission. Brain Res Rev 55:17-54.
35. Gaytan O, Swann A, Dafny N. 1998a. Time-dependent differences in the rat's motor response to amphetamine. Pharmacol Biochem Behav 59:459-467.
36. Gaytan O, Swann A, Dafny N. 1998b. Diurnal differences in rat's motor response to amphetamine. Eur J Pharmacol 345:119-128.
37. Gonon FG. 1988. Nonlinear relantionship between impulse flow and dopamine released by rat midbrain dopaminergic neurons as studies by in vivo electrochemistry. Neuroscience 24:19-28.
38. Grace AA. 1991. Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: A hypothesis for the etiology of schizophrenia. Neuroscience 41:1-24.
39. Grace AA, Bunney BS. 1983. Intracellular and extracellular electrophysiology of nigral dopaminergic neurons-1. Identification and characterization. Neuroscience 10:301-315.
40. Grillner P, Mercuri NB. 2002. Intrinsic membrane properties and synaptic inputs regulating the firing activity of the dopamine neurons. Behav Brain Res 130:149-169.
41. Hnasko TS, Hjelmstad GO, Fields HL, Edwards RH. 2012. Ventral tegmental area glutamate neurons: electrophysiological properties and projections. J Neurosci 32:15076-15085.
42. Houben T, Deboer T, van Oosterhout F, Meijer JH. 2009. Correlation with behavioral activity and rest implies circadian regulation by SCN neuronal activity levels. J Biol Rhythms 24:477-487.
43. Inouye ST, Kawamura H. 1979. Persistence of circadian rhythmicity in a mammalian hypothalamic "island" containing the suprachiasmatic nucleus. Proc Natl Acad Sci USA 76:5962-5966.
44. Jeziorski M, White FJ. 1989. Dopamine agonists at repeated "autoreceptor-selective" doses: Effects upon the sensitivity of A10 dopamine autoreceptors. Synapse 4:267-280.
45. Jiang ZG, Nelson CS, Aller CN. 1995. Melatonin activates an outward current and inhibits Ih in rat suprachiasmatic nucleus neruons. Brain Res 687:125-132.
46. Kafka MS, Benedito MA, Roth RH, Steele LK, Wolfe WW, Catravas GN. 1986. Circadian rhythms in catecholamine metabolites and cyclic nucleotide production. Chronobiol Int 3:101-115.
47. Khaldy H, Leon J, Escames G, Bikjdaouene L, Garcia JJ, Acuna-Castroviejo D. 2002. Circadian rhythms of dopamine and dihydroxyphenyl acetic acid in the mouse striatum: Effects of pinealectomy and of melatonin treatment. Neuroendocrinology 75:201-208.
48. Lentz MJ. 1990. Time-series analysis-cosinor analysis: A special case. West J Nurs Res 12:408-412.
49. Liu T, Borjigin J. 2006. Relationship between nocturnal serotonin surge and melatonin onset in rodent pineal gland. J Circadian Rhythms 4:12.
50. Luo A, Georges F, Aston-Jones G. 2008 Novel neurons in ventral tegmental area fire selectively during the active phase of the diurnal cycle. Eur J Neurosci 27:408-422.
51. Luo AH, Aston-Jones G. 2009. Circuit projection from suprachiasmatic nucleus to ventral tegmental area: A novel circadian output pathway. Eur J Neurosci 29:748-760.
52. Mason R, Brooks A. The electrophysiological effects of melatonin and a putative melatonin antagonist (N-acetyltryptamine) on rat suprachiasmatic neurones in vitro. Neurosci Lett 95:296-301.
53. McClung CA, Sidiropoulou K, Vitaterna M, Takahashi JS, White FJ, Cooper DC, Nestler EJ. 2005. Regulation of dopaminergic transmission and cocaine reward by the Clock gene. Proc Natl Acad Sci USA 102:9377-9381.
54. Mercuri NB, Calabresi P, Benardi G. 1992. The electrophysiological actions of dopamine and dopaminergic drugs on neurons of the substantia nigra pars compacta and ventral tegmental area. Lif Sci 51:711-718.
55. Millan MJ, Maiofiss L, Cussac D, Audinot V, Boutin JA, Newman-Tancredi A. 2002. Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned human receptor subtypes. J Pharmacol Exp Ther 303:791-804.
56. Millan MJ, Gobert A, Lejeune F, Dekeyne A, Newman-Tancredi A, Pasteau V, Rivet J-M, Cussac D. 2003. The novel melatonin agonist agomelatine (S20098) is an antagonist at 5-hydroxytryptamine 2C receptors, blockade of which enhances the activity of frontocortical dopaminergic and adrenergic pathways. J Pharmacol Exp Ther 306:954-964.
57. Mukherjee S, Coque L, Cao JL, Kumar J, Chakravarty S, Asaithamby A, Graham A, Gordon E, Enwright JF 3rd, DiLeone RJ, Birnbaum SG, Cooper DC, McClung CA. 2010. Knockdown of Clock in the ventral tegmental area through RNA interference results in a mixed state of mania and depression-like behavior. Biol Psychiatry 68:503-511.
58. Morin LP. 2013. Neuroanatomy of the extended circadian rhythm system. Exp Neurol 243:4-20.
59. Morzorati SL, Marunde RL, Downey D. 2010. Limited access to ethanol increases the number of spontaneously active dopamine neurons in the posterior ventral tegmental area of nondependent P rats. Alcohol 44:257-264.
60. Nelson CS, Marino JL, Allen CN. 1996. Melatonin receptors activate heteromeric G-protein coupled Kir3 channels. Neuroreport 7:717-720.
61. Ondo WG. 2011. Motor complications in Parkinson's disease. Int J Neurosci 121(Suppl 2):37-44.
62. O'Neill RD, Fillenz M. 1985. Simultaneous monitoring of dopamine release in rat frontal cortex, nucleus accumbens and striatum: Effect of drugs, circadian changes and correlations with motor activity. Neuroscience 16:49-55.
63. Owasoyo JO, Walker CA, Whitworth UG. 1979. Diurnal variation in the dopamine level of rat brain areas: Effect of sodium phenobarbital. Life Sci 25:119-122.
64. Panin F, Cathala A, Piazza PV, Spampinato U. 2012. Coupled intracerebral microdialysis and electrophysiology for the assessment of dopamine neuron function in vivo. J Pharmacol Toxicol Methods 65:83-92.
65. Paulson PE, Robinson TE. 1996. Regional differences in the effects of amphetamine withdrawal on dopamine dynamics in the striatum. Analysis of circadian patterns using automated on-line microdialysis. Neuropsychopharmacology 14:325-337.
66. Paxinos G, Watson C. 2007. The rat brain in stereotaxic coordinates. Amsterdam: Elsevier Press.
67. Radhakishun FS, Westerink BH, van Ree JM. 1988. Dopamine release in the nucleus accumbens of freely moving rats determined by on-line dialysis: Effects of apomorphine and the neuroleptic-like peptide desenkephalin-gamma-endorphin. Neurosci Lett 89:328-334.
68. Rebec GV, Bashore TR, Zimmerman KS, Alloway KD. 1979. "Classical" and "atypical" antipsychotic drugs: differential antagonism of amphetamine- and apomorphine-induced alterations of spontaneous neuronal activity in the neostriatum and nucleus accumbens. Pharmacol Biochem Behav 11:529-538.
69. Reppert SM, Weaver DR. 2001. Molecular analysis of mammalian circadian rhythms. Annu Rev Physiol 63:647-676.
70. Robinson DL, Venton BJ, Heien ML, Wightman RM. 2003. Detecting subsecond dopamine release with fast-scan cyclic voltammetry in vivo. Clin Chem 49:1763-1773.
71. Shi WX, Pun CL, Smith PL, Bunney BS. 2000. Endogenous DA-mediated feedback inhibition of DA neurons: Involvement of both D1- and D2-like receptors. Synapse 35:111-119.
72. Shi WX. 2009. Electrophysiological characteristics of dopamine neurons: A 35-year update. J Neural Transm Suppl:103-119.
73. Simonneaux V, Ribelayga C. 2003. Generation of the melatonin endocrine message in mammals: A review of the complex regulation of melatonin synthesis by norepinephrine, peptides, and other pineal transmitters. Pharmacol Rev 55:325-395.
74. Skirboll LR, Grace AA, Bunney B. 1979. Dopamine auto- and postsynaptic receptors: electrophysiological evidence for differential sensitivity to dopamine agonists. Science 206:80-82.
75. Sleipness EP, Jansen HT, Schenk JO, Sorg BA. 2008. Time-of-day differences in dopamine clearance in the rat medial prefrontal cortex and nucleus accumbens. Synapse 62:877-885.
76. Sleipness EP, Sorg BA, Jansen HT. 2007. Diurnal differences in dopamine transporter and tyrosine hydroxylase levels in rat brain: Dependence on the suprachiasmatic nucleus. Brain Res 1129:34-42.
77. Sombers LA, Beyene M, Carelli RM, Wightman RM. 2009. Synaptic overflow of dopamine in the nucleus accumbens arises from neuronal activity in the ventral tegmental area. J Neurosci 29:735-1742.
78. Sulzer D. 2011. How addictive drugs disrupt presynaptic dopamine neurotransmission. Neuron 69:628-649.
79. Sulzer D, Sonders MS, Poulsen NW, Galli A. 2005. Mechanisms of neurotransmitter release by amphetamines: A review. Prog Neurobiol 75:406-433.
80. Torner C, Sánchez-Hurtado L, Aguilar-Roblero R. 1998. Diurnal variations of striatal D2 dopaminergic receptors and its relation with haloperidol-induced catalepsy. Biol Rhythm Res 29:538-545.
81. Ungless MA, Grace AA. 2012. Are you or aren't you? Challenges associated with physiologically identifying dopamine neurons. Trends Neurosci 35:422-430.
82. Ungless MA, Magill PJ, Bolam JP. 2004. Uniform inhibition of dopamine neurons in the ventral tegmental area by aversive stimuli. Science 303:2040-2042.
83. Uz T, Arslan AD, Kurtuncu M, Imbesi M, Akhisaroglu M, Dwivedi Y, Pandey GN, Manev H. 2005. The regional and cellular expression profile of the melatonin receptor MT1 in the central dopaminergic system. Brain Res Mol Brain Res 136:45-53.
84. Valenti O, Grace AA. 2010. Antipsychotic drug-induced increases in ventral tegmental area dopamine neuron population activity via activation of the nucleus accumbens-ventral pallidum pathway. Int J Neuropsychopharmacol 13:845-860.
85. Webb IC, Baltazar RM, Wang X, Pitchers KK, Coolen LM, Lehman MN. 2009. Diurnal variations in natural and drug reward, mesolimbic tyrosine hydroxylase, and clock gene expression in the male rat. J Biol Rhythms 24:465-476.
86. Weber M, Lauterburg T, Tobler I, Burgunder JM. 2004. Circadian patterns of neurotransmitter related gene expression in motor regions of the rat brain. Neurosci Lett 358:17-20.
87. White FJ, Wang RY. 1984a. A10 dopamine neurons: role of autoreceptors in determining firing rate and sensitivity to dopamine agonists. Life Sci 34:1161-1170.
88. White FJ, Wang RY. 1984b. Pharmacological characterization of dopamine autoreceptors in the rat ventral tegmental area: microiontophoretic studies. J Pharmacol Exp Ther 231:275-280.
89. Wolfe GW, Bousquet WF, Schnell RC. 1977. Circadian variations in response to amphetamine and chlorpromazine in the rat. Commun Psychopharmacol 1:29-37.
90. Zhang H, Kiyatkin EA, Stein EA. 1994. Behavioral and pharmacological modulation of ventral tegmental dendritic dopamine release. Brain Res 656:59-70.
91. Zeise ML, Semm P. 1985. Melatonin lowers excitability of guinea pig hippocampal neurons in vitro. J Comp Physiol A 157:23-29.
92. Zisapel N. 2001. Melatonin-dopamine interactions: From basic neurochemistry to a clinical setting. Cell Mol Neurobiol 21:605-616.